Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 8% in 2025, with fewer blockbusters; Brinsupri, Rhapsido make it to first-in-class list

    Data Compilation
    #PharmaFlow

    Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

    Stock Recap
    #PipelineProspector

    Menu

    Ruxolitinib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 25,173Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    27/02/2026 Shandong Chenghui Shuangda Pharmaceutical
    China
    		 Pharmapia Co., Ltd. Su258-55-ND Luxolitinib phosphate 2026-02-20 Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. China Economic Development Zone, Pingyuan County, Dezhou City, Shandong, PRChina
    27/02/2026 Chongqing Huapont Pharmaceutical
    China
    		 Ace Biopharm Co., Ltd. Su289-32-ND Luxolitinib phosphate 2025-05-14 Chongqing Huapont Shengchem Pharmaceutical Co., Ltd. China No. 666 Rongjun Road, Nanjin Avenue Hechuan District, Chongqing China
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.